Clinical Trials Logo

Pulmonary Valve Stenosis clinical trials

View clinical trials related to Pulmonary Valve Stenosis.

Filter by:

NCT ID: NCT05828524 Recruiting - Clinical trials for Congenital Heart Disease

Outcome of Balloon Pulmonary Valvuloplasty in Patients With Congenital Pulmonary Stenosis in Terms of Reverse Right Ventricular Remodelling and Functional Exercise Capacity

Start date: January 10, 2021
Phase:
Study type: Observational

A prospective of 30 patients with symptomatic severe congenital valvular pulmonary stenosis who are indicated for percutaneous balloon pulmonary valvuloplasty . the aim is to 1. - evaluate electrical and mechanical remodeling of RV 6 months following balloon dilation 2. - evaluate Functional capacity using 6MWT and SaO2 before and 6 months following BPV

NCT ID: NCT05582213 Completed - Clinical trials for Congenital Pulmonary Stenosis

Effect of Ketamine Versus Sevoflurane On The Right Ventricular Pressure

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to compare the effect of different anesthetic drugs used for induction of anesthesia ketamine versus sevoflurane on the RV pressure in pediatrics undergoing balloon dilatation for congenital pulmonary stenosis.

NCT ID: NCT05452720 Recruiting - Clinical trials for Transposition of Great Vessels

MASA Valve Early Feasibility Study

MVEFS
Start date: May 18, 2023
Phase: N/A
Study type: Interventional

The MASA Valve Early Feasibility Study (MVEFS) multi-site interventional clinical trial within the United States of America with each center following a common protocol.The objective of the trial is to evaluate the safety and probable benefit of MASA Valve in the indicated subset of patients requiring Right Ventricular Outflow Tract Reconstruction (RVOTR). As an early feasibility study, the purpose is determine the feasibility of success of the device in order to gather early data towards a future pivotal study and/or regulatory clearance submission.

NCT ID: NCT05090228 Completed - Clinical trials for Pulmonary Valve Insufficiency

Right Ventricle Remodeling After Pulmonary Valve Replacement and Percutaneous Pulmonary Valve Insertion

RV-REPAIR
Start date: February 1, 2016
Phase:
Study type: Observational

This study investigates damage of the right cardiac chamber in adult patients with a congenital heart defect involving the pulmonary valve (the heart valve between the right cardiac chamber and the lungs). The investigators want to investigate if novel, less invasive techniques are feasible to assess damage of this right cardiac chamber, to improve follow-up and timing of intervention (valve replacement) in this group of patients.

NCT ID: NCT04960085 Not yet recruiting - Clinical trials for Right Ventricular Dysfunction

Role of Echocardiography in the Assessment of Right Ventricular Function in the Pediatric Population With Valvular Pulmonary Stenosis.

Start date: July 2, 2021
Phase:
Study type: Observational

Correct assessment of right ventricular function by transthoracic echocardiographic examination in pediatric patients with congenital valvular pulmonary stenosis after Percutaneous Balloon Pulmonary Valvuloplasty

NCT ID: NCT04452188 Completed - Clinical trials for Cardiopulmonary Bypass

Targeting Normoxia in Neonates With Cyanotic Congenital Heart Disease in the Intra-operative and Immediate Post-operative Period

T-NOX
Start date: January 18, 2021
Phase: N/A
Study type: Interventional

This clinical trial is studying the use of different levels of oxygen exposure during and after cardiopulmonary bypass in eligible infants to learn about its safety during heart surgery. In addition to having the various doses of oxygen, participants will also have blood samples, ultrasounds of the head, and brain wave patterns monitored. The hypotheses of this trial are: - that there will be no difference with regards to adverse events between the infants in the normoxia group compared to the infants in the standard of care group - there will be a significant difference in the measured partial pressure of oxygen (PaO2) values between the two treatment groups. - the use of normoxia during cardiopulmonary bypass and in the immediate post-operative period will result in clinically significant decrease in oxidative stress as measured by thiobarbituric acid reactive substances (TBARS) after cardiac surgery

NCT ID: NCT04017975 Active, not recruiting - Clinical trials for Ventricular Septal Defect

Optical Tissue Identification for Myocardial Architecture

OPTIMA
Start date: December 20, 2019
Phase: Phase 2
Study type: Interventional

The goal of this study is to test the hypothesis that fiberoptic confocal microscopy (FCM) imaging during repair of common congenital heart defects is a useful adjunct for avoidance of conduction abnormalities.

NCT ID: NCT03983512 Active, not recruiting - Heart Diseases Clinical Trials

PULSTA Transcatheter Pulmonary Valve Pre-Approval Study

Start date: October 7, 2019
Phase: N/A
Study type: Interventional

The purpose of the study is to evaluate the safety and effectiveness of the PULSTA Transcatheter Pulmonary Valve (TPV) System for the treatment of congenital or acquired pulmonary valve stenosis and/or regurgitation who require pulmonary valve replacement.

NCT ID: NCT03441971 Active, not recruiting - Clinical trials for Heart Defects, Congenital

Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction

Start date: June 7, 2018
Phase: N/A
Study type: Interventional

This study will assess the safety and performance of the GORE PV1 Device for replacement of the pulmonary valve and reconstruction of the Right Ventricular Outflow Tract (RVOT).

NCT ID: NCT03110861 Active, not recruiting - Clinical trials for Congenital Heart Defect

Pulsta® Transcatheter Pulmonary Valve Korean Multicenter Study

Start date: March 22, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of the TPV in patients with pulmonary valve dysfunction.